Pharma I – Drug Discovery and Preclinical Development
Course content
This course provides an overview of the pre-clinical phase of discovery and development of medical drugs. The participants will be able to communicate professionally with the various specialist groups within the area of drug development.
The topics taught are:
- Target finding and translational validation
- Small-molecule hit identification and lead optimisation
- Peptides and proteins as drugs
- Non-clinical safety
BRIDGE – Translational Excellence Programme
Upon completing the course, participants should be able to:
Knowledge
- Give an overview of the pre-clinical phase of discovery and development of medicines.
- Identify correct professional terms in drug discovery and pre-clinical development of medicines.
- List major steps and elements of the pre-clinical drug development process.
- Outline definitions of key concepts and the fundamentals of the major disciplines in drug discovery and pre-clinical development.
Skills
- Appraise the integration of the various basic disciplines into the process of discovery and pre-clinical development of medicines.
- Analyse the sequence and flow of the various steps in the process of drug discovery and pre-clinical development.
Competences
- Liaise with all steps of drug discovery and pre-clinical development.
- Identify critical factors and bottlenecks that influence the pre-clinical drug development process.
- Promote and state milestones for the progress of the pre-clinical development of a medical product.
- Communicate professionally with the various specialist groups within the area of development of medicines.
The course is organised with a mix of scientific seminars by
invited speakers, including technical lectures on modern
technologies.
The first five course days of the Pharma I course correspond to
week one of the course “Discovery and Development of Medicines”,
held in the professional master’s programmes "Master of
Industrial Drug Development" (MIND) and "Master of
Medicines Regulatory Affairs" (MRA). MIND, MRA, and BRIDGE
participants are taught together during this week. The sixth course
day is only for BRIDGE participants. For the BRIDGE participants,
the course includes group project work, where the participants will
study and describe the discovery of a known drug in an oral
presentation to the plenary.
The course will end with an evaluation, where participants must
reflect on the course learning outcomes and provide feedback for
course development.
The course literature will be listed on Absalon.
Participants must meet the admission criteria of the BRIDGE – Translational Excellence Programme.
The BRIDGE – Translational Excellence Programme offers a few selected PhD graduates a two-year postdoctoral fellowship in translational medicine. This course is only available to the fellows enrolled in the programme. Fellows are automatically enrolled in this course upon admission to the programme.
For further information about the programme, please visit the website: www.bridge.ku.dk
- ECTS
- 0 ECTS
- Type of assessment
-
Continuous assessmentRequirement to attend classes
- Type of assessment details
- Attendance and active participation are required, including completing a group work assignment.
- Examination prerequisites
-
Participants are automatically registered for the examination upon admission to the BRIDGE – Translational Excellence Programme.
- Aid
- All aids allowed
- Marking scale
- passed/not passed
- Censorship form
- No external censorship
Criteria for exam assessment
Active contribution and course participation according to the BRIDGE Guidelines and Practicalities.
Part time Master and Diploma courses
- Category
- Hours
- Lectures
- 20
- Preparation
- 20
- Practical exercises
- 2
- Project work
- 8
- English
- 50
Kursusinformation
- Language
- English
- Course number
- SBRI19005U
- ECTS
- 0 ECTS
- Programme level
- Part Time Master
Ph.D.
- Placement
- Spring
- Schedulegroup
-
See course dates and programme in Absalon.
- Capacity
- 15 participants
- Studyboard
- Study Board for the Professionel Master´s Degree Programmes at The Faculty og Health and Medical Science
Contracting department
- Department of Drug Design and Pharmacology
Contracting faculty
- Faculty of Health and Medical Sciences
Course Coordinator
- Anders Bach (11-6a776d6e7b7c376b6a6c71497c7e776d37747e376d74)
Er du BA- eller KA-studerende?
Kursusinformation for indskrevne studerende